Pharmacogenomics-based treatment of Helicobacter pylori infection.
D000900:Anti-Bacterial Agents / Q000493:pharmacokinetics / Q000627:therapeutic use; D044466:Asian People; D018795:Device Approval; D005767:Gastrointestinal Diseases / Q000188:drug therapy*; D005838:Genotype; D016481:Helicobacter Infections / Q000188:drug therapy / Q000208:ethnology / Q000235:genetics*; D016480:Helicobacter pylori; D006801:Humans; D010597:Pharmacogenetics; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome; D014481:United States
D000900:Anti-Bacterial Agents